BR112015028249A2 - substância ativa para o tratamento da sarcopenia - Google Patents

substância ativa para o tratamento da sarcopenia

Info

Publication number
BR112015028249A2
BR112015028249A2 BR112015028249A BR112015028249A BR112015028249A2 BR 112015028249 A2 BR112015028249 A2 BR 112015028249A2 BR 112015028249 A BR112015028249 A BR 112015028249A BR 112015028249 A BR112015028249 A BR 112015028249A BR 112015028249 A2 BR112015028249 A2 BR 112015028249A2
Authority
BR
Brazil
Prior art keywords
active substance
sarcopenia
treatment
muscle
collagen hydrolyzate
Prior art date
Application number
BR112015028249A
Other languages
English (en)
Inventor
Kneféli Hans-Christoph
Frech Hans-Ulrich
Oesser Steffen
Hausmanns Stephan
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50588721&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015028249(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of BR112015028249A2 publication Critical patent/BR112015028249A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

resumo patente de invenção: "substância ativa para o tratamento da sarcopenia". a presente invenção refere-se a um hidrolisado de colágeno como substância ativa para o tratamento da sarcopenia, como substância ativa contra a perda degenerativa da massa muscular e para melhorar a força muscular, como substância ativa para reduzir a perda da massa muscular inerente à idade, e como substância ativa para estimular a transformação da massa de gordura corporal em massa muscular. a invenção refere-se, além disso, a um processo para o tratamento da sarcopenia, compreendendo a administração oral repetida de hidrolisado de colágeno em um paciente.
BR112015028249A 2013-05-13 2014-04-29 substância ativa para o tratamento da sarcopenia BR112015028249A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013104897.8A DE102013104897A1 (de) 2013-05-13 2013-05-13 Wirkstoff zur Behandlung von Sarkopenie
PCT/EP2014/058673 WO2014183989A1 (de) 2013-05-13 2014-04-29 Wirkstoff zur behandlung von sarkopenie

Publications (1)

Publication Number Publication Date
BR112015028249A2 true BR112015028249A2 (pt) 2017-07-25

Family

ID=50588721

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015028249A BR112015028249A2 (pt) 2013-05-13 2014-04-29 substância ativa para o tratamento da sarcopenia

Country Status (15)

Country Link
US (2) US20160051618A1 (pt)
EP (1) EP2996710B1 (pt)
CN (1) CN105209059B (pt)
AU (1) AU2014267613B2 (pt)
BR (1) BR112015028249A2 (pt)
CA (1) CA2928222C (pt)
CL (2) CL2015003326A1 (pt)
DE (1) DE102013104897A1 (pt)
DK (1) DK2996710T3 (pt)
ES (1) ES2857652T3 (pt)
MX (1) MX369238B (pt)
PL (1) PL2996710T3 (pt)
PT (1) PT2996710T (pt)
RU (1) RU2679802C2 (pt)
WO (1) WO2014183989A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013104897A1 (de) 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
DE102018104590A1 (de) * 2018-02-28 2019-08-29 Gelita Ag Nutrazeutische oder pharmazeutische Zusammensetzung
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US6476005B1 (en) * 1998-03-24 2002-11-05 George D. Petito Oral and injectable nutritional composition
US6107460A (en) * 1999-03-01 2000-08-22 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use thereof
US8211477B2 (en) * 2007-10-17 2012-07-03 Biova, L.L.C. Solubilized protein composition obtained from eggshell membrane
DE102009030351A1 (de) * 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
TWI526161B (zh) * 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
DE102010060564A1 (de) * 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
US10869843B2 (en) * 2010-11-23 2020-12-22 Chemi Nutra Method for increasing muscle mass and strength
DE102011000997A1 (de) * 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
WO2012143324A1 (en) * 2011-04-19 2012-10-26 Bioiberica, S.A. Cartilage product
US20130065823A1 (en) * 2011-09-14 2013-03-14 Sergio Ammirata Supplement for Strengthening the Muscles of a Human
WO2014030514A1 (ja) 2012-08-24 2014-02-27 国立大学法人徳島大学 筋委縮抑制剤
DE102012110612A1 (de) 2012-11-06 2014-05-08 Gelita Ag Kollagenhydrolysat und dessen Verwendung
US20140296137A1 (en) * 2013-04-01 2014-10-02 Los Alamos National Security, Llc Methods and compositions for controlling rotifers
DE102013104897A1 (de) 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie

Also Published As

Publication number Publication date
RU2015153242A3 (pt) 2018-03-01
WO2014183989A1 (de) 2014-11-20
AU2014267613A1 (en) 2015-11-26
EP2996710B1 (de) 2021-03-03
MX2015015680A (es) 2016-03-15
DK2996710T3 (da) 2021-03-29
RU2015153242A (ru) 2017-06-19
RU2679802C2 (ru) 2019-02-13
CN105209059A (zh) 2015-12-30
US20190151399A1 (en) 2019-05-23
MX369238B (es) 2019-11-01
ES2857652T3 (es) 2021-09-29
CA2928222C (en) 2021-02-16
PT2996710T (pt) 2021-03-26
US20160051618A1 (en) 2016-02-25
EP2996710A1 (de) 2016-03-23
CL2018003346A1 (es) 2019-02-01
CA2928222A1 (en) 2014-11-20
AU2014267613B2 (en) 2017-06-15
CL2015003326A1 (es) 2016-07-15
CN105209059B (zh) 2021-11-02
PL2996710T3 (pl) 2021-06-28
DE102013104897A1 (de) 2014-11-13

Similar Documents

Publication Publication Date Title
PH12015501740A1 (en) Sodium channel modulators for the treatment of pain
BR112013023803A2 (pt) dispositivo para inervação magnética extracorpórea
NZ701607A (en) Therapeutic use of chardonnay seed products
SG10201805552PA (en) Sodium channel modulators for the treatment of pain and diabetes
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
PH12015502302B1 (en) Treatment of allergic rhinitis using a combination of mometasone and olopatadine
CL2018003346A1 (es) Uso de hidrolizado de colágeno para preparar un medicamento contra la pérdida degenerativa de masa muscular (sarcopenia) y para mejorar la fuerza muscular (divisional de solicitud 3326-2015).
EP3960186A3 (en) Promoting bone health and repair and treating disorders related to collagen and pertinent proteins by using shilajit
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2018002223A (es) Derivados de insulina novedosos y usos medicos de los mismos.
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
MX2012008492A (es) Aparato para reducir los sintomas de las enfermedades neurodegerativas.
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
EA201390530A1 (ru) Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями
MX2018000287A (es) Dispositivo de electroestimulacion.
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
UA113183C2 (xx) Спосіб лікування адикції
UA110451C2 (en) Method for stimulating reparative processes in patients with severe periodontitis
EA201990676A1 (ru) Лечение остеоартрита
EA201990553A1 (ru) Применение придопидина для лечения ухудшения функциональной способности
UA105274C2 (ru) Способ стимуляции роста костной мозоли по индриксону
RU2013154077A (ru) Способ биологической стрессовой психотерапии (биостресспсихотерапии)
UA96506U (uk) Спосіб лікування нейропатій
GB201304462D0 (en) Therapeutic vaccine for treatment of type 2 diabetes and impaired glucose tolerance
UA91323U (uk) Спосіб прискорення росту волосся за індріксоном

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2542 DE 24/09/2019 POR TER SIDO INDEVIDA.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122023002213-0 PROTOCOLO 870230010562 EM 06/02/2023 15:26.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]